CIPHER PHARMACEUTICALS INC's ticker is CPHRF and the CUSIP is 17253X105. A total of 18 filers reported holding CIPHER PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $8,533,000 | +17.6% | 1,941,100 | -7.6% | 1.23% | +3.9% |
Q1 2017 | $7,256,000 | -5.2% | 2,100,600 | 0.0% | 1.19% | -15.5% |
Q4 2016 | $7,653,000 | -5.9% | 2,100,600 | -1.6% | 1.40% | -11.5% |
Q3 2016 | $8,135,000 | -63.2% | 2,134,200 | -51.7% | 1.58% | -30.9% |
Q2 2016 | $22,082,000 | +104.2% | 4,415,500 | +96.4% | 2.29% | +6.0% |
Q1 2016 | $10,812,000 | +9.9% | 2,248,400 | +7.3% | 2.16% | +6.8% |
Q4 2015 | $9,834,000 | +76.7% | 2,095,200 | +39.1% | 2.03% | +63.1% |
Q3 2015 | $5,566,000 | -42.1% | 1,506,600 | +34.0% | 1.24% | -34.4% |
Q2 2015 | $9,608,000 | +4208.5% | 1,124,100 | +4451.0% | 1.90% | +3931.9% |
Q1 2015 | $223,000 | -26.4% | 24,700 | +17.6% | 0.05% | -30.9% |
Q4 2014 | $303,000 | +13.1% | 21,000 | -35.4% | 0.07% | +17.2% |
Q2 2014 | $268,000 | – | 32,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Raffles Associates | 447,800 | $2,125,000 | 2.48% |
Grandeur Peak Global Advisors, LLC | 2,248,400 | $10,812,000 | 2.16% |
TAYLOR ASSET MANAGEMENT INC | 1,193,700 | $5,736,000 | 1.49% |
MONTRUSCO BOLTON INVESTMENTS INC. | 2,313,061 | $11,159,000 | 0.92% |
AWM Investment Company, Inc. | 250,000 | $1,200,000 | 0.25% |
INTACT INVESTMENT MANAGEMENT INC. | 528,600 | $3,277,000 | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 705,884 | $3,407,000 | 0.02% |
Creative Planning | 15,000 | $71,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 85 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 296 | $1,000 | 0.00% |